Company Overview of Althea Technologies, Inc.
Althea Technologies, Inc., a contract development and manufacturing company, engages in cGMP manufacturing, analytical development, aseptic filling into vials and syringes, and protein delivery technology for recombinant protein and parenteral products. It offers biologics manufacturing services, such as process development, microbial and yeast expression systems, product expertise, fermentor capacity, and complex formulations; and protein analytics stability testing services, including method development and validation, product characterization, comparability studies, reference standard qualification, and stability and release testing. The company also provides asethic fill and finish servi...
11040 Roselle Street
San Diego, CA 92121
Founded in 1997
Key Executives for Althea Technologies, Inc.
Chief Executive Officer and President
Chief Financial Officer and Senior Vice President
Senior Vice President of Operations
President of Bio-Services Division
Compensation as of Fiscal Year 2013.
Althea Technologies, Inc. Key Developments
Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement for Plasmid DNA Production
Feb 26 13
Althea Technologies, Inc. and Profectus BioSciences Inc. announced the signing of a manufacturing supply agreement for plasmid DNA production. Under the agreement, Althea will provide gram-scale quantities of cGMP (current Good Manufacturing Practice) manufactured plasmid DNA expressing IL-12 to assist Profectus Biosciences' ongoing DNA vaccine development efforts, which are supported by a contract from the National Institutes of Health. IL-12 helps prompt an immune response once the DNA enters a cell, which is part of Profectus Biosciences' technology platform designed to overcome the poor delivery and immunogenicity of many DNA vaccines.
Althea Technologies, Inc. Presents at The BIOCOM 3rd Annual Global Life Science Partnering Conference, Feb-28-2013 11:20 AM
Feb 18 13
Althea Technologies, Inc. Presents at The BIOCOM 3rd Annual Global Life Science Partnering Conference, Feb-28-2013 11:20 AM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.
Althea Technologies, Inc. Announces Promotion of Executives
Sep 24 12
Althea Technologies, Inc. announced the promotion of Rick Hancock to the position of President and CEO, Chris Duffy to Senior Vice President of Operations and E.J. Brandreth to Senior Vice President of Quality and Regulatory. The promotion of the company's experienced science and technology leaders supports the company's continued commitment to building and maintaining a robust and dynamic management team. Mr. Rick Hancock was formerly President of Althea. Mr. Hancock has worked in the biotechnology industry for 30 years and held positions at Hybritech/Eli Lilly, Genetics Institute, and The Immune Response Corporation, before joining Althea in 1998. In his new position as President and CEO, Mr. Hancock will play a stronger role in the development of strategies to continue Althea's growth and success. Mr. Chris Duffy, who began his career at Althea twelve years ago, has also been instrumental in the development of the company. He has over twenty-six years of experience in the biotech industry managing biopharmaceutical development and sterile manufacturing operations. When Mr. Duffy first joined Althea, he managed the Quantitative PCR group, and has since held positions of increasing responsibility in operations management. Mr. Duffy's expertise in science and business will contribute to Althea's continued growth as he moves to his new role as Sr. Vice President of Operations. Mr. E.J. Brandreth likewise has had over twenty years of experience in the biotechnology and pharmaceutical industries, having managed numerous agency inspections and led the process validation programs for five CBER/EMEA product launches. Additionally, Mr. Brandreth serves on BIOCOM'S FDA Committee, Interphex's Advisory Board, and PDA's Biotech Advisory Board as Chairman. Prior to Althea, Mr. Brandreth was with Favrille and Biomarin where he supported a variety of clinical products and launched two commercial products. He joined Althea over four years ago, and has successfully led Althea through a PAI inspection and two unscheduled FDA inspections. In his new role as Sr. Vice President of Quality and Regulatory, Mr. Brandreth will play a critical role in leading Althea into its future expansion of commercial operations.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|